- The European Medicines Agency (EMA) is expected to take the first decision approving the covid-19 vaccine on December 29.
- The decision applies to Pfizer / Biontech’s vaccine candidate.
- “We work hard to make a decision then,” says Charlotta Bergquist at the Medical Products Agency, who participates in the review of the vaccine.
Should the reviewers have several questions for the pharmaceutical company, the decision can be moved to January, according to Charlotta Bergquist. The decision concerning the vaccine candidate from Moderna, which will be taken up in the EMA on 12 January, is also expected.
At a vaccine approval, first comes a recommendation from the EMA’s Scientific Committee, and then it is the European Commission that makes the formal decision. After that, it is allowed to sell the vaccine throughout the EU.
When the vaccine arrives in Sweden, it is the Public Health Agency’s responsibility to transport the vaccine doses to the regions. The transports must be ready after the Christmas and New Year weekend.
– We are in the middle of the procurement process, which will be completed in the coming weeks. Then we can provide more information about the details. As soon as possible after the weekends, this should be up and running, says Sören Andersson, head of the unit for vaccination programs at the Swedish Public Health Agency.
Source: ICELAND NEWS